Straterra: A Safer Desipramine?
The Carlat Psychiatry Report, Volume 1, Number 4, April 2003
https://www.thecarlatreport.com/newsletter-issue/tcprv1n4/
Issue Links: | Editorial Information
Topics: ADHD
Daniel Carlat, MD
Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.
The Eli Lilly reps are almost delirious about their new ADHD “miracle drug”, Straterra (atomoxetine). This is not surprising.
You can't view details of this content, please login or buy subscription here